Candidiasis – Causes, Symptoms, Treatment, Antifungal Diet

The principal mechanism facilitating colonization and pathogenic overgrowth of *Candida* species fungi is immune system dysfunction, precipitated by both chronic metabolic disorders (e.g., hyperglycemia in type 1 and type 2 diabetes mellitus) and secondary immunosuppressed states—including HIV infection, glucocorticoid therapy, or biologically modified immune response inhibitors. Iatrogenic factors play a similarly critical role, particularly broad-spectrum antibiotics, which—by eradicating competitive bacterial flora in the gut and mucosal surfaces—create an ecological niche for opportunistic microorganisms. Hormonal imbalances (e.g., elevated estrogen levels during pregnancy, fluctuations in the perimenopausal period) and exogenous administration of synthetic hormones (oral contraceptives, hormone replacement therapy) alter local microenvironmental conditions, thereby facilitating fungal cell adhesion and invasion. Additionally, disturbances in carbohydrate metabolism—both congenital (e.g., glucose transporter defects) and acquired (insulin resistance)—generate elevated concentrations of energetic substrates in bodily fluids, providing an optimal medium for the proliferation of *Candida albicans* and related species. A diet deficient in prebiotics and polyphenols but rich in high-glycemic-index simple sugars, fermented alcohols, and ultra-processed foods exacerbates intestinal dysbiosis and systemic inflammatory responses, cumulatively increasing susceptibility to fungal infections. Behavioral factors, such as chronic oxidative stress (linked to insufficient regenerative sleep or excessive psychological burden), tobacco smoking (particularly in the context of oral candidiasis among poorly fitted or inadequately cleaned denture wearers), and wearing non-breathable synthetic clothing (e.g., polyester), promote localized moisture retention and elevated skin temperature, predisposing individuals to dermatological and mucosal infections. Epidemiological research (including Rodrigues et al., 2019; Bouopda Tamo, 2020) confirms that the interplay of these endogenous and exogenous determinants governs both the prevalence and clinical severity of candidiasis.

Among the most prevalent manifestations is **oral candidiasis** (colloquially termed "thrush" or "oral moniliasis"), characterized by the presence of creamy-white, removable plaques on the dorsal surface of the tongue, palatal mucosa, and buccal membranes. Associated symptoms include burning or stabbing pain, odynophagia (painful swallowing), and occasional bleeding upon mechanical plaque disruption. **Vulvovaginal candidiasis** presents with intense pruritus, erythema, tissue edema, and thick, curd-like vaginal discharge, frequently resulting in dyspareunia (painful intercourse) and dysuria (urinary discomfort). **Cutaneous candidiasis** predominantly affects moist, warm anatomical regions—such as intertriginous folds (e.g., submammary, inguinal), interdigital spaces, and the perineum—manifesting as erythematous maceration, fissuring of the epidermis, and severe itching. **Candida onychomycosis** involves dystrophic nail plate alterations: hypertrophy, friability, yellowish-brown discoloration, and onycholysis (separation from the nail bed). The less commonly identified **gastrointestinal candidiasis** is associated with dyspeptic complaints—abdominal distension, diarrhea, colicky pain, nausea, and generalized malaise. The most severe form, **invasive (systemic) candidiasis**, occurs when *Candida* species disseminate hematogenously, precipitating fungal sepsis with pyrexia, myalgia/arthralgia, and—in advanced stages—parenchymal organ damage (hepatic, renal, cardiac) and multi-organ failure (cf. Bouopda Tamo S.P., 2020).

The diagnostic workflow for infections caused by *Candida* species commences with an exhaustive medical history assessment, during which the clinician meticulously evaluates the patient’s reported symptoms alongside potential predisposing factors, including but not limited to chronic comorbid conditions, long-term pharmaceutical regimens, or prior antibiotic treatment courses. When oral or vaginal candidiasis is suspected, the diagnostic protocol further incorporates a thorough physical examination coupled with the collection of biological specimens—via swab sampling from inflamed mucosal surfaces—for subsequent laboratory analysis. Confirmation of the diagnosis typically necessitates specialized microbiological testing, encompassing fungal culture with strain identification and susceptibility profiling to determine the most effective antifungal therapeutic agents. In advanced or systemic manifestations of the disease, such as disseminated candidiasis, diagnostic expansion may include hematological assays or imaging modalities, particularly when internal organ involvement is suspected (as documented in clinical research by S.P. Bouopda Tamo, 2020).

The clinical management of candidiasis is contingent upon both the specific subtype of infection and its progression dynamics. In mild presentations—primarily involving superficial cutaneous lesions, oral mucosal involvement, or anogenital regions—the cornerstone of therapy comprises topical antifungal formulations, including dermatological creams, vaginal gels, or oral rinse solutions containing active antifungal agents. The most frequently employed compounds belong to the azole class, such as fluconazole (administered in weight-adjusted doses), clotrimazole (demonstrating broad-spectrum efficacy against *Candida albicans*), and miconazole (which exhibits supplementary antibacterial properties). When the infection manifests as a systemic condition—such as candidemia with hematogenous dissemination or visceral candidiasis affecting organs like the liver, kidneys, or central nervous system—systemic antifungal therapy becomes imperative. Treatment regimens in these cases rely on oral or parenteral administration of high-potency agents, including polyenes (e.g., liposomal amphotericin B to mitigate adverse effects) and newer-generation triazoles (such as voriconazole or posaconazole for fluconazole-resistant strains). A critical determinant of therapeutic success is the identification and mitigation of underlying risk factors, which may include primary or secondary immunodeficiency states (e.g., HIV/AIDS or post-transplant immunosuppression), prolonged antibiotic use, poorly controlled diabetes mellitus, and the administration of corticosteroids or immunosuppressive drugs. For recurrent infections—confirmed via microbiological testing—secondary prophylaxis with low-dose azoles over several months is recommended, in alignment with the 2019 guidelines issued by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).

Implementation of an antifungal dietary protocol constitutes a significant therapeutic component in addressing the overgrowth of *Candida albicans* and other pathogenic fungal microorganisms. While contemporary scientific research does not provide definitive evidence that diet alone can completely inhibit fungal proliferation, a thoughtfully constructed meal plan can substantially contribute to optimizing gut microbiota composition, modulating the body’s immunological responses, and accelerating tissue regenerative processes. The core principle of this nutritional approach involves the systematic exclusion of foods that serve as potential nutrient sources for yeasts—particularly simple sugars, refined carbohydrates, and fermented products—while simultaneously incorporating ingredients with documented prebiotic, anti-inflammatory, and immunomodulatory properties, such as cruciferous vegetables, healthful fats, and plant-based probiotic beverages.

Fungal organisms belonging to the *Candida* genus primarily metabolize monosaccharides and disaccharides, which serve as their principal energy substrate for growth and colonization. Consequently, an effective dietary intervention necessitates the complete removal of the following food categories:

— confectionery items with elevated sucrose content, including chocolate bars, candies, ice cream, and pastry products;

— sugar-sweetened carbonated beverages, commercial fruit juices (even those labeled "100% pure"), as well as high-fructose corn syrups and honey-based preparations;

— so-called *ready-to-eat* products (commonly referred to as *convenience foods*), *fast-food* meals, and ultra-processed foodstuffs containing preservatives, emulsifiers, and artificial additives (see: Otašević et al., research published in 2018).

While fruits constitute a valuable source of essential micronutrients, vitamins, and dietary fiber, their excessive consumption—particularly of varieties high in readily absorbable carbohydrates—may disrupt microbiological balance and foster the proliferation of pathogenic microorganisms, including fungi. Within the framework of antifungal elimination diets aimed at combating fungal infections, it is advisable to prioritize fruits characterized by a low glycemic index and reduced fructose content, such as avocados, grapefruits, raspberries, blackberries, strawberries, or green kiwifruit. Conversely, it is necessary to significantly restrict—or even temporarily exclude—fruits with elevated monosaccharide concentrations, including grapes (especially raisins), ripe bananas, mangoes, pineapples, and dried fruits (cf. Otašević et al., 2018, whose research highlights a correlation between fructose-rich diets and heightened *Candida spp.* activity).

Dietary fiber serves an irreplaceable function in modulating the gut microbiota’s homeostatic balance by acting as an energy substrate for probiotic bacterial strains. Through stimulation of colonic fermentation pathways, it promotes the biosynthesis of short-chain fatty acids—including acetate, propionate, and butyrate—whose immunomodulatory and anti-inflammatory properties have been extensively validated in meta-analytical research. The most nutritionally dense dietary sources include: • whole-grain cereals with intact bran layers (such as buckwheat, wild rice, and sourdough rye bread), • root and leafy vegetables with high insoluble fiber fractions, • legumes (lentils, chickpeas, adzuki beans), • berry fruits and citrus varieties rich in pectin, • tree nuts and seeds (flaxseed, chia, sunflower seeds)—as systematically reviewed by Jawhara (2023) in the "Journal of Nutritional Biochemistry".

Emerging research demonstrates that specific lipid profiles—particularly those abundant in monounsaturated and polyunsaturated fatty acids—exhibit substantial inhibitory effects against pathogenic fungal species such as *Candida* alongside other opportunistic microorganisms. Beyond their antimicrobial potential, consistent dietary inclusion of these fats facilitates the restoration of compromised intestinal epithelial integrity, thereby enhancing mucosal immune defenses. The most valuable dietary sources include: • extra-virgin olive oil (rich in oleic acid and bioactive polyphenolic compounds), • unrefined flaxseed oil (a primary source of alpha-linolenic acid, ALA), • fatty cold-water fish—including Atlantic salmon, mackerel, and sardines (providing eicosapentaenoic acid, EPA, and docosahexaenoic acid, DHA, from the omega-3 family), • tree nuts, particularly walnuts and hazelnuts (containing phytosterols and tocopherol), • pumpkin and sunflower seeds (supplying immune-supportive minerals such as zinc and magnesium). These findings are corroborated by a 2023 meta-analysis conducted by Jawhara et al., which highlights the synergistic role of these nutritional components in preventing intestinal candidiasis and modulating gut microbiota composition.

Fermented food products serve as a rich reservoir of probiotic bacterial strains—primarily from the *Lactobacillus* and *Bifidobacterium* genera—which play a pivotal role in restoring balanced intestinal microbiota and reinforcing the mucosal barrier of the gastrointestinal tract. For this reason, it is strongly advised to regularly incorporate a diverse array of fermented dairy items—such as unsweetened yogurt, kefir, buttermilk, and cottage cheese—alongside traditional lacto-fermented vegetables, sourdough bread, and fermented beverages like kombucha into one’s daily diet (Jawhara, 2023). Adopting an antifungal dietary regimen not only facilitates the management of *Candida* overgrowth but also yields broader health benefits. By replacing ultra-processed foods with nutrient-dense alternatives—including dietary fiber, polyunsaturated fatty acids, and live microbial cultures—this approach enhances digestive efficiency, bolsters immune resilience, and mitigates systemic inflammatory responses.